What is Kura Oncology's EBITDA margin?

Kura Oncology (KURA) reported EBITDA margin of -441.9% in Q1 2026.

How has Kura Oncology's EBITDA margin changed year-over-year?

Kura Oncology's EBITDA margin decreased by 18.9% year-over-year, from -371.6% to -441.9%.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Kura Oncology KURA EBITDA margin

EBITDA margin at other companies

Johnson & JohnsonJNJ

34.4%+2.7pp

AmgenAMGN

41.5%+3.4pp

ExelixisEXEL

40.6%+6.2pp

AbbVieABBV

37.3%—

Nuvation BioNUVB

-103.6%-51.3pp

Arcus BiosciencesRCUS

-164.8%-51.5pp

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$942.78M+81.6%

Enterprise value$927.97M+90.7%

P/S13.2×+3.6×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Calculated from Kura Oncology’s reported figures.

ebitda/total revenue=-441.9%

Based on trailing twelve months.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's EBITDA margin?: Kura Oncology (KURA) reported EBITDA margin of -441.9% in Q1 2026.
How has Kura Oncology's EBITDA margin changed year-over-year?: Kura Oncology's EBITDA margin decreased by 18.9% year-over-year, from -371.6% to -441.9%.
What does EBITDA margin mean?: EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.